|1.||Reis, A: 1 article (05/2005)|
|2.||Spelsberg, H: 1 article (05/2005)|
|3.||Reinhard, T: 1 article (05/2005)|
|4.||Mayweg, S: 1 article (05/2005)|
|5.||Sundmacher, R: 1 article (05/2005)|
|6.||Godehardt, E: 1 article (05/2005)|
|7.||Reinhard, Thomas: 1 article (04/2005)|
|8.||Böhringer, Daniel: 1 article (04/2005)|
|9.||Sundmacher, Rainer: 1 article (04/2005)|
|10.||Birnbaum, Florian: 1 article (04/2005)|
01/01/1977 - "[Experiences with oral Ultralan in the treatment of rheumatoid arthritis]."
11/01/1999 - "The therapeutic efficacy and tolerability of the combination of cyclosporin A, methotrexate and fluocortolone was evaluated after 96 months of treatment in 140 patients with rheumatoid arthritis. "
11/01/1999 - "Long-term efficacy and toxicity of cyclosporin A + fluocortolone + methotrexate in the treatment of rheumatoid arthritis."
|2.||Autoimmune Diseases (Autoimmune Disease)
10/15/1989 - "[The combination of cyclosporin A and fluocortolone in the treatment of autoimmune diseases]."
10/15/1989 - "The results obtained demonstrate the efficacy of CyA in treatment of autoimmune diseases and show that association with fluocortolone and/or methotrexate and cyclophosphamide by exploiting the combined action of these drugs, has enabled relatively low doses to be used. "
10/15/1989 - "The authors report the results obtained in treatment of various autoimmune diseases using cyclosporin A (CyA) in association with fluocortolone and/or methotrexate and cyclophosphamide. "
|3.||Psoriasis (Pustulosis Palmaris et Plantaris)
01/01/1983 - "A multicentre, between-patient, comparative trial was carried out by nine dermatologists in the Federal Republic of Germany to compare the efficacy and tolerability of 0.05 halometasone ointment with those of an ointment, containing 0.25% fluocortolone + 0.25% fluocortolone caproate, in patients with psoriasis vulgaris. "
01/01/1983 - "A comparative multicentre trial of halometasone ointment and fluocortolone plus fluocortolone caproate ointment in the treatment of psoriasis."
08/01/1974 - "Local treatment of psoriasis and eczema with betamethasone-17,21-dipropionate (Diproderm cream): a double-blind comparsion with fluocortolone caproate, fluocortolone pivalate (Ultralanum cream)."
01/01/1971 - "[Epitopical and occlusive therapy in skin diseases, using fluocortolone (FMC). "
06/01/1970 - "[Ultralan in the therapy of certain skin diseases]."
04/01/1969 - "[Result of "Ultralan" therapy of some dermatoses]."
04/15/1988 - "Every 7 patients out of a total of 21 patients suffering from various skin diseases were daily treated with 40 g of one of the 3 corticoid preparations over 8 days (group A: 0.05% clobetasol-17-propionate; group B: 0.25% fluocortolone trimethyl acetate; group C: 0.25% fluocortolone trimethyl acetate + 0.25% fluocortolone capronate). "
|5.||Rheumatic Diseases (Rheumatism)
04/01/1996 - "Fluocortolone is a potent corticosteroid used orally for the treatment of rheumatic diseases, asthma, and immunosuppression. "
07/27/1990 - "Suppression of endogenous cortisol production was assessed by a corticotropin-releasing hormone (CRH) test 24 hours after the last dose of the glucocorticoid in 48 patients (27 women and 21 men; mean age 48.9 [21-69] years) who had been taking fluocortolone for inflammatory rheumatic disease. "
|9.||Ouabain (G Strophanthin)
|10.||Immunosuppressive Agents (Immunosuppressants)
|3.||Electric Countershock (Cardioversion)